Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Acq. announced
Director departure
Quarterly results

BioMed Realty L P Create: Alert

All | News | Filings
Date FiledTypeDescription
02/08/2016 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
01/29/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
01/29/2016 4 Gold Alan D (Chairman, President and CEO) has filed a Form 4 on BioMed Realty L P
Txns: Disposed/sold 17,144 shares @ $0
Disposed/sold 17,144 shares @ $0
Disposed/sold 161,894 shares @ $0
Disposed/sold 161,894 shares @ $0
Disposed/sold 928,098 shares @ $0
Disposed/sold 928,098 shares @ $0
Disposed/sold 56,822 shares @ $0
Disposed/sold 56,822 shares @ $0
Disposed/sold 52,500 options to buy @ $23.8239, valued at $1.3M
Disposed/sold 52,500 options to buy @ $23.8239, valued at $1.3M
Disposed/sold 12,950 options to buy @ $0
01/29/2016 4 Kreitzer Gary A (Exec VP and Assistant Sec) has filed a Form 4 on BioMed Realty L P
Txns: Disposed/sold 11,309 shares @ $0
Disposed/sold 98,406 shares @ $0
Disposed/sold 80,000 shares @ $0
Disposed/sold 642,528 shares @ $0
Disposed/sold 35,879 options to buy @ $0
01/29/2016 4 Berens James R (President, Wexford) has filed a Form 4 on BioMed Realty L P
Txns: Disposed/sold 272,491 shares @ $0
01/27/2016 8-K Resignation/termination of a director
Docs: "BLACKSTONE COMPLETES ACQUISITION OF BIOMED REALTY TRUST"
01/06/2016 8-K Other Events
01/04/2016 4 Kreitzer Gary A (Exec VP & Assist Sec) has filed a Form 4 on BioMed Realty L P
Txns: Disposed/sold 45,000 options to buy @ $23.75, valued at $1.1M
Disposed/sold 45,000 options to buy @ $23.75, valued at $1.1M
01/04/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Form of Executive Restricted Cash Award Grant Notice and Restricted Cash Award Agreement",
"Equity Award Acceleration and Share Restriction Agreement, between BioMed Realty Trust, Inc. and Alan D. Gold",
"Equity Award Acceleration and Share Restriction Agreement, between BioMed Realty Trust, Inc. and Greg N. Lubushkin",
"Equity Award Acceleration and Share Restriction Agreement, between BioMed Realty Trust, Inc. and Gary A. Kreitzer",
"Equity Award Acceleration and Share Restriction Agreement, between BioMed Realty Trust, Inc. and James R. Berens",
"Equity Award Acceleration and Share Restriction Agreement, between BioMed Realty Trust, Inc. and John P. Bonanno",
"Equity Award Acceleration and Share Restriction Agreement, between BioMed Realty Trust, Inc. and Jonathan P. Klassen",
"Equity Award Acceleration and Share Restriction Agreement, between BioMed Realty Trust, Inc. and Karen A. Sztraicher",
"Form of Best Pay Cap Letter Agreement",
"LTIP Unit Award Cancellation Agreement, between BioMed Realty Trust, Inc., BioMed Realty, L.P. and Gary A. Kreitzer"
11/05/2015 10-Q Quarterly Report for the period ended September 30, 2015
10/08/2015 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among BioMed Realty Trust, Inc., BRE Edison Holdings L.P., BRE Edison L.P., BRE Edison Acquisition L.P. and BioMed Realty, L.P. (the Company hereby agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request)",
"Fourth Amended and Restated Bylaws of BioMed Realty Trust, Inc",
"BIOMED REALTY ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY BLACKSTONE FOR $23.75 PER SHARE IN $8 BILLION TRANSACTION"
10/08/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/28/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Equity Distribution Agreement, among the Company, the Operating Partnership and Raymond James & Associates, Inc",
"Opinion of Venable LLP"
07/29/2015 10-Q Quarterly Report for the period ended June 30, 2015
05/29/2015 8-K Material Impairments, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "BIOMED REALTY TRUST SELLS KING OF PRUSSIA PROPERTY IN RADNOR TO PENN MEDICINE FOR $35 MILLION"
04/29/2015 10-Q Quarterly Report for the period ended March 31, 2015
04/15/2015 4 Gold Alan D (Chairman, President and CEO) has filed a Form 4 on BioMed Realty L P
Txns: Converted 7,250 shares @ $0
Converted 7,250 shares @ $0
Exercised 7,250 options to buy @ $0
02/25/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Transition and Consulting Agreement effective as of February 25, 2015 among BioMed Realty Trust, Inc., BioMed Realty, L.P. and Kent Griffin",
"BIOMED REALTY ANNOUNCES REALIGNMENT TO LEVERAGE DEPTH OF LIFE SCIENCE REAL ESTATE EXPERTISE AND INCREASE SHAREHOLDER VALUE As Part of Realignment, Company Announces Departure of Kent Griffin, President & Chief Operating Officer SAN DIEGO, CA - February 25, 2015 - Today, BioMed Realty Trust, Inc. announced a realignment, including a number of promotions and additions to its leadership team focused on the execution of the company's strategy to increase shareholder returns through strategic investments in real estate at the intersection of the growing health care industry and the innovation sector. The company also announced that, effective today, Kent Griffin is leaving his role as President and Chief Operating Officer to pursue other business opportunities. During his nine-year career with ..."
02/06/2015 10-K Annual Report for the period ended December 31, 2014
02/02/2015 4 BioMed Realty Trust Inc (10% Owner) has filed a Form 4 on Zosano Pharma Corp
Txns: Converted 64,661 shares @ $9.35, valued at $604.6k
Converted 64,661 shares @ $9.35, valued at $604.6k
Bought 26,543 shares @ $11, valued at $292k
Converted 317,409 shares @ $9.35, valued at $3M
Converted 337,150 options to buy @ $0
Converted 1,101,393 options to buy @ $0
Converted 267,446 options to buy @ $0
Converted 1,148,956 options to buy @ $0
Converted 717,437 options to buy @ $0
01/16/2015 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
01/02/2015 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Employment Transition and Consulting Agreement effective as of December 30, 2014 among BioMed Realty Trust, Inc., BioMed Realty, L.P. and Matthew G. McDevitt",
"Employment Transition and Consulting Agreement effective as of December 30, 2014 among BioMed Realty Trust, Inc., BioMed Realty, L.P. and Matthew G. McDevitt"
12/15/2014 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
12/12/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Notice of Redemption"
12/12/2014 SC TO-I Form SC TO-I - Tender offer statement by Issuer:
10/30/2014 10-Q Quarterly Report for the period ended September 30, 2014
08/06/2014 10-Q Quarterly Report for the period ended June 30, 2014
05/01/2014 10-Q Quarterly Report for the period ended March 31, 2014
04/23/2014 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Supplemental Indenture No. 3, by and among BioMed Realty, L.P., BioMed Realty Trust, Inc. and U.S. Bank National Association, as trustee, including the",
"Opinion of Venable LLP",
"Opinion of Latham & Watkins LLP"
04/17/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, among the Company, the Operating Partnership and Deutsche Bank Securities Inc. and Wells Fargo Securities, LLC, as representatives of the Underwriters"
04/16/2014 424B2 Form 424B2 - Prospectus [Rule 424(b)(2)]
04/15/2014 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
02/13/2014 4 Gold Alan D (Chairman and CEO) has filed a Form 4 on BioMed Realty L P
Txns: Converted 10,500 shares @ $0
Converted 10,500 shares @ $0
Exercised 10,500 options to buy @ $0
Exercised 10,500 options to buy @ $0
02/07/2014 10-K Annual Report for the period ended December 31, 2013
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy